530 related articles for article (PubMed ID: 31096977)
1. Cost-effectiveness of a community-based cardiovascular disease prevention intervention in medically underserved rural areas.
Wang H; Kenkel D; Graham ML; Paul LC; Folta SC; Nelson ME; Strogatz D; Seguin RA
BMC Health Serv Res; 2019 May; 19(1):315. PubMed ID: 31096977
[TBL] [Abstract][Full Text] [Related]
2. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY; Ko SK; Liew D
Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of a physician deployment program to improve access to healthcare in rural and underserved areas in the Philippines.
Avanceña ALV; Tejano KPS; Hutton DW
BMJ Open; 2019 Dec; 9(12):e033455. PubMed ID: 31888937
[TBL] [Abstract][Full Text] [Related]
4. Strong Hearts, healthy communities: a rural community-based cardiovascular disease prevention program.
Seguin RA; Eldridge G; Graham ML; Folta SC; Nelson ME; Strogatz D
BMC Public Health; 2016 Jan; 16():86. PubMed ID: 26822982
[TBL] [Abstract][Full Text] [Related]
5. Strong Hearts for New York: A multilevel community-based randomized cardiovascular disease risk reduction intervention for rural women.
Seguin RA; Graham ML; Eldridge G; Nelson ME; Strogatz D; Folta SC; Paul L
Contemp Clin Trials; 2019 Jul; 82():17-24. PubMed ID: 31129372
[TBL] [Abstract][Full Text] [Related]
6. Process Evaluation of Strong Hearts, Healthy Communities: A Rural Community-Based Cardiovascular Disease Prevention Program.
Sriram U; Sandreuter K; Graham M; Folta S; Pullyblank K; Paul L; Seguin R
J Nutr Educ Behav; 2019 Feb; 51(2):138-149. PubMed ID: 30738562
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program (SNAP): A microsimulation study.
Mozaffarian D; Liu J; Sy S; Huang Y; Rehm C; Lee Y; Wilde P; Abrahams-Gessel S; de Souza Veiga Jardim T; Gaziano T; Micha R
PLoS Med; 2018 Oct; 15(10):e1002661. PubMed ID: 30278053
[TBL] [Abstract][Full Text] [Related]
8. Improvements in dietary intake, behaviors, and psychosocial measures in a community-randomized cardiovascular disease risk reduction intervention: Strong Hearts, Healthy Communities 2.0.
MacMillan Uribe AL; Demment M; Graham ML; Szeszulski J; Rethorst CD; Githinji P; Nelson ME; Strogatz D; Folta SC; Bailey RL; Davis JN; Seguin-Fowler RA
Am J Clin Nutr; 2023 Nov; 118(5):1055-1066. PubMed ID: 37717638
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Three Doses of a Behavioral Intervention to Prevent or Delay Type 2 Diabetes in Rural Areas.
Radcliff TA; Côté MJ; Whittington MD; Daniels MJ; Bobroff LB; Janicke DM; Perri MG
J Acad Nutr Diet; 2020 Jul; 120(7):1163-1171. PubMed ID: 31899170
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project.
Sović N; Pająk A; Jankowski P; Duenas A; Kawecka-Jaszcz K; Wolfshaut-Wolak R; Stepaniak U; Kawalec P
Kardiol Pol; 2013; 71(7):702-11. PubMed ID: 23907903
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of a statewide public health intervention to reduce cardiovascular disease risk.
Smith L; Atherly A; Campbell J; Flattery N; Coronel S; Krantz M
BMC Public Health; 2019 Sep; 19(1):1234. PubMed ID: 31492118
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease.
Pandya A; Sy S; Cho S; Weinstein MC; Gaziano TA
JAMA; 2015 Jul; 314(2):142-50. PubMed ID: 26172894
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of the SLIMMER diabetes prevention intervention in Dutch primary health care: economic evaluation from a randomised controlled trial.
Duijzer G; Bukman AJ; Meints-Groenveld A; Haveman-Nies A; Jansen SC; Heinrich J; Hiddink GJ; Feskens EJM; de Wit GA
BMC Health Serv Res; 2019 Nov; 19(1):824. PubMed ID: 31711499
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Diet and Exercise for Overweight and Obese Patients With Knee Osteoarthritis.
Losina E; Smith KC; Paltiel AD; Collins JE; Suter LG; Hunter DJ; Katz JN; Messier SP
Arthritis Care Res (Hoboken); 2019 Jul; 71(7):855-864. PubMed ID: 30055077
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Rural Incentive Packages for Graduating Medical Students in Lao PDR.
Keuffell E; Jaskiewicz W; Theppanya K; Tulenko K
Int J Health Policy Manag; 2017 Jul; 6(7):383-394. PubMed ID: 28812834
[TBL] [Abstract][Full Text] [Related]
17. Changes in diet and physical activity resulting from the Strong Hearts, Healthy Communities randomized cardiovascular disease risk reduction multilevel intervention trial.
Folta SC; Paul L; Nelson ME; Strogatz D; Graham M; Eldridge GD; Higgins M; Wing D; Seguin-Fowler RA
Int J Behav Nutr Phys Act; 2019 Oct; 16(1):91. PubMed ID: 31653260
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of different screening strategies for primary prevention of cardiovascular diseases in a rural northern Chinese population].
Si YQ; Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Liu JJ; Gao P; Hu YH
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):443-449. PubMed ID: 29930411
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease prevention in rural Nigeria in the context of a community based health insurance scheme: QUality Improvement Cardiovascular care Kwara-I (QUICK-I).
Hendriks M; Brewster L; Wit F; Bolarinwa OA; Odusola AO; Redekop W; Bindraban N; Vollaard A; Alli S; Adenusi P; Agbede K; Akande T; Lange J; Schultsz C
BMC Public Health; 2011 Mar; 11():186. PubMed ID: 21439057
[TBL] [Abstract][Full Text] [Related]
20. Direct healthcare costs and cost-effectiveness of acute coronary syndrome secondary prevention with ticagrelor compared to clopidogrel: economic evaluation from the public payer's perspective in Poland based on the PLATO trial results.
Pawęska J; Macioch T; Perkowski P; Budaj A; Niewada M
Kardiol Pol; 2014; 72(9):823-30. PubMed ID: 24846362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
